Orthocell Granted European Tendon Regeneration Patent

Securing this patent for tendon repair in Europe is another milestone in strengthening our IP position as we drive our novel world leading tendon repair product into the global market. Orthocell is focused on building and maintaining patent protection for our regenerative medicine technologies and treatment processes, Orthocell Managing Director Paul Anderson said. Global IP protection for Ortho-ATI  further underpins the international rollout of Orthocell’s world-leading tendon repair technology. Orthocell is well positioned to commercialize Ortho-ATI  with mature manufacturing facilities in place, proven safety, and efficacy, published clinical data and a clear pathway to market.